Type 2 diabetes elicits lower nitric oxide, bradykinin concentration and kallikrein activity together with higher DesArg9-BK and reduced post-exercise hypotension compared to non-diabetic condition

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Simões, Herbert Gustavo ^a,f   Asano, Ricardo Yukio ^a   Sales, Marcelo Magalhães ^a   Browne, Rodrigo Alberto Vieira ^a   Arsa, Gisela ^b   Motta Santos, Daisy ^c   Puga, Guilherme Morais ^d,e   Lima, Laila Cândida De Jesus ^a   Campbell, Carmen Sílvia Grubert ^a   Franco, Octavio Luiz ^a,f  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^e FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^f FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ[1-8]; KALLIKREIN; NITRIC OXIDE;

ADULT; ARTICLE; BICYCLE ERGOMETER; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN CONSUMPTION; POST EXERCISE HYPOTENSION; SYSTOLIC BLOOD PRESSURE;

EID: 84893106856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080348     Document Type: Article

References (39)

1. Frontoni S, Bracaglia D, Gigli F (2005) Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes. Nutr Metab Cardiovasc Dis 15: 441-449. doi:10.1016/j.numecd.2005.06.010. PubMed: 16314230.
2. Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P (2001) Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Diabetes Metab 27: 436-447. PubMed: 11547217.
3. Resnick HE, Howard BV (2002) Diabetes and cardiovascular disease. Annu Rev Med 53: 245-267. doi:10.1146/annurev.med.53.082901.103904. PubMed: 11818473.
4. Zhu W, Zhong C, Yu Y, Li K (2007) Acute effects of hyperglycaemia with and without exercise on endothelial function in healthy young men. Eur J Appl Physiol 99: 585-591. doi:10.1007/s00421-006-0378-3. PubMed: 17206439.
5. Miche E, Herrmann G, Nowak M, Wirtz U, Tietz M et al. (2006) Effect of an exercise training program on endothelial dysfunction in diabetic and non-diabetic patients with severe chronic heart failure. Clin Res Cardiol 95 Suppl 1: i117-i124. doi:10.1007/s00392-006-1106-z. PubMed: 16598538.
6. Motta DF, Lima LCJ, Arsa G, Russo PS, Sales MM et al. (2010) Effect of type 2 diabetes on plasma kallikrein activity after physical exercise and its relationship to post-exercise hypotension. Diabetes Metab 36: 363-368. doi:10.1016/j.diabet.2010.03.008. PubMed: 20579916.
7. Morais PK, Campbell CSG, Sales MM, Motta DF, Moreira SR et al. (2011) Acute resistance exercise is more effective than aerobic exercise for 24h blood pressure control in type 2 diabetics. Diabetes Metab 37: 112-117. doi:10.1016/j.diabet.2010.08.008. PubMed: 21159536.
8. Sales MM, Russo P, Moreira SR, Santana H, Moraes JF et al. (2012) Resistance Exercise Elicits Acute Blood Pressure Reduction in Type 2 Diabetics. J Exerc Physiol Online 15: 98-109. doi:10.3205/11esm136.
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572. doi:10.1001/jama.289.19.2560. PubMed: 12748199.
10. Moreira S, Simões G, Hiyane W, Campbell C, Simões H (2007) Identification of the anaerobic threshold in sedentary and physically active individuals with type 2 diabetes. Braz J Phys Ther 11: 253-259. doi:10.1590/S1413-35552007000400008.
11. Belli T, Ackermann MA, Ribeiro LFP, Langeani R, Galdino da Silva R et al. (2007) Lactate and ventilatory thresholds in type 2 diabetic women. Diabetes Res Clin Pract 76: 18-23. doi:10.1016/j.diabres.2006.07.028. PubMed: 16959365.
12. Meyer T, Görge G, Schwaab B, Hildebrandt K, Walldorf J et al. (2005) An alternative approach for exercise prescription and efficacy testing in patients with chronic heart failure: a randomized controlled training study. Am Heart J 149: e1-e7. doi:10.1016/j.ahj.2004.12.006. PubMed: 15894947.
13. Sales MM, Campbell CSG, Morais PK, Ernesto C, Soares-Caldeira LF et al. (2011) Noninvasive method to estimate anaerobic threshold in individuals with type 2 diabetes. Diabetol Metab Syndr 3: 1. doi:10.1186/1758-5996-3-1. PubMed: 21226946.
14. Simões HG, Moreira SR, Moffatt RJ, Campbell CSG (2010) Methods to identify the anaerobic threshold for type-2 diabetic and non-diabetic subjects. Arq Bras Cardiol 94: 71-78. doi:10.1590/S0066-782X2010000100012. PubMed: 20414529.
15. Lima LCJ, Assis GV, Hiyane W, Almeida WS, Arsa G et al. (2008) Hypotensive effects of exercise performed around anaerobic threshold in type 2 diabetic patients. Diabetes Res Clin Pract 81: 216-222. doi:10.1016/j.diabres. 2008.04.019. PubMed: 18571267.
16. Jermendy G (2003) Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetol 40 Suppl 2: S370-S374. doi:10.1007/s00592-003-0122-y. PubMed: 14704871.
17. Tentolouris N, Argyrakopoulou G, Katsilambros N (2008) Perturbed autonomic nervous system function in metabolic syndrome. Neuromol Med 10: 169-178. doi:10.1007/s12017-008-8022-5. PubMed: 18224460.
18. Sakr HF (2010) Endothelial Dysfunction Induced by Type 2 Diabetes Mellitus and Fibrinolytic Activity. Am J Biochem Biotechnol 6: 103-110. doi:10.3844/ajbbsp.2010.103.110.
19. Nyström T, Nygren A, Sjöholm A (2006) Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin Sci (Lond) 110: 673-681. doi:10.1042/CS20050353. PubMed: 16466346.
20. Malik M, Bigger JT, Camm AJ, Kleiger RE, Malliani A et al.; (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93: 1043-1065. doi:10.1161/01.CIR.93.5.1043. PubMed: 859806810.1161/ 01.CIR.93.51043. Pubmed: 8598068. doi:10.1161/01.CIR.93.5.1043. PubMed: 8598068.
21. Simões HG, Hiyane WC, Benford RE, Madrid B, Prada FA et al. (2010) Lactate Threshold Prediction By Blood Glucose and Rating of Perceived Exertion in People With Type 2 Diabetes. Percept Mot Skills 111: 365-378. doi:10.2466/06.13.15.27.PMS.111.5.365-378. PubMed: 21162440.
22. Howley ET, Bassett DR, Welch HG (1995) Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc 27: 1292-1301. PubMed: 8531628.
23. Moraes MR, Bacurau RFP, Ramalho JDS, Reis FCG, Casarini DE et al. (2007) Increase in kinins on post-exercise hypotension in normotensive and hypertensive volunteers. Biol Chem 388: 533-540. doi:10.1515/BC.2007.055. PubMed: 17516849.
24. Lottenberg R, Christensen U, Jackson CM, Coleman PL (1981) Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol 80: 341-61 Pt C: 341-361 PubMed: 6210826.
25. Okada Y, Tsuda Y, Tada M, Wanaka K, Hijikata-Okunomiya A et al. (1999) Development of plasma kallikrein selective inhibitors. Biopolymers 51: 41-50. doi:10.1002/(SICI)1097-0282(1999)51:1〈41::AID-BIP5〉3.0.CO;2-Y. PubMed: 10380351.
26. Wanaka K, Okamoto S, Bohgaki M, Hijikata-Okunomiya A, Naito T et al. (1990) Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysis. Thromb Res 57: 889-895. doi:10.1016/0049-3848(90)90155-6. PubMed: 2382257.
27. Raymond P, Drapeau G, Raut R, Audet R, Marceau F et al. (1995) Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods 180: 247-257. doi:10.1016/0022-1759(94)00320-V. PubMed: 7714339.
28. Granger DL, Anstey NM, Miller WC, Weinberg JB (1999) Measuring nitric oxide production in human clinical studies. Methods Enzymol 301: 49-61(99)01068-X doi:10.1016/S0076-6879(99)01068-X. PubMed: 9919553.
29. Jaffa AA, Durazo-Arvizu R, Zheng D, Lackland DT, Srikanth S et al. (2003) Plasma Prekallikrein: A Risk Marker for Hypertension and Nephropathy in Type 1 Diabetes. Diabetes 52: 1215-1221. doi:10.2337/diabetes.52.5.1215. PubMed: 12716755.
30. Stabler T, Kenjale A, Ham K, Jelesoff N, Allen J (2010) Potential mechanisms for reduced delivery of nitric oxide to peripheral tissues in diabetes mellitus. Ann N Y Acad Sci 1203: 101-106. doi:10.1111/j.1749-6632.2010. 05599.x. PubMed: 20716290.
31. Augeri AL, Tsongalis GJ, Van Heest JL, Maresh CM, Thompson PD et al. (2009) The endothelial nitric oxide synthase -786 T>C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure. Atherosclerosis 204: e28-e34. doi:10.1016/j. atherosclerosis.2008.12.015. PubMed: 19155013.
32. Cubbon RM, Murgatroyd SR, Ferguson C, Bowen TS, Rakobowchuk M et al. (2010) Human exercise-induced circulating progenitor cell mobilization is nitric oxide-dependent and is blunted in South Asian men. Arterioscler Thromb Vasc Biol 30: 878-884. doi:10.1161/ATVBAHA.109.201012. PubMed: 20110574.
33. Taguchi T, Kishikawa H, Motoshima H, Sakai K, Nishiyama T et al. (2000) Involvement of bradykinin in acute exercise-induced increase of glucose uptake and GLUT-4 translocation in skeletal muscle: studies in normal and diabetic humans and rats. Metabolism 49: 920-930. doi:10.1053/mt.2000.6755. PubMed: 10910005.
34. Pontes FL, Bacurau RFP, Moraes MR, Navarro F, Casarini DE et al. (2008) Kallikrein kinin system activation in post-exercise hypotension in water running of hypertensive volunteers. Int Immunopharmacol 8: 261-266. doi:10.1016/j.intimp.2007.09.001. PubMed: 18182237.
35. Carnethon MR, Jacobs DR, Sidney S, Liu K (2003) Influence of Autonomic Nervous System Dysfunction on the Development of Type 2 Diabetes: The CARDIA study. Diabetes Care 26: 3035-3041. doi:10.2337/diacare.26.11.3035. PubMed: 14578236.
36. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C et al. (2007) Relationship between oxidative stress and essential hypertension. Hypertens Res 30: 1159-1167. doi:10.1291/hypres.30.1159. PubMed: 18344620.
37. Grossman E (2008) Does increased oxidative stress cause hypertension? Diabetes Care 31 Suppl 2: S185-S189. doi:10.2337/dc08-s246. PubMed: 18227483.
38. Sharma JN, Narayanan P (2012) Hypertension and Diabetes: Contribution of the Kallikrein - Kinin System. Diabetes Metab 01. doi:10.4172/2155-6156.S4-004.
39. Rohlfing CL, Wiedmeyer H-M, Little RR, England JD, Tennill A et al. (2002) Defining the Relationship Between Plasma Glucose and HbA1c: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 25: 275-278. doi:10.2337/diacare.25.2.275. PubMed: 11815495.